Yes, planned breaks are safe when medically necessarysuch as before surgery or during severe side effects
Schauer, Jo E
I think the analysis could benefit from a comparison of healthcare costs between a control group of obese and morbidly obese patients by an age cohort race ethnicity and gender vs those with a healthy weight as background over time
Employer Coverage Trends Despite cost concerns, most large employers with existing GLP-1 coverage plan to continue it: 90% of large employers currently covering GLP-1s plan to maintain coverage in 2026 [13] 44% of employers with 500+ employees cover weight loss medications (up from prior years) [14] 64% of employers with 20,000+ employees offer coveragethe largest employers are most likely to cover [14] Cost impact: Covering GLP-1s may increase employer premiums by ~514%, driving some to add restrictions [15] Note: All 2026 timelines, pricing, and coverage expansions are subject to federal rulemaking, final CMS implementation, and individual state/employer decisions
Mounjaro's dual-hormone approach, versatility in dosage options, and potential for greater weight loss differentiate it from Retatrutide, offering a comprehensive and effective weight management solution
Azelaic acid: Evidence-based update on mechanism of action and clinical application